Rheingold, Valet, Rheingold & Giuffra LLP has filed suit against many different Reglan manufacturers throughout New York and New Jersey. As such, we keep up on the latest information and litigation related to this drug.
Recent Court Decisions
The Superior Court of New Jersey consolidated the Reglan/Metoclopramide litigation in Atlantic County under Judge Higbee. We are deeply involved in this litigation and hold a leadership position amongst the Plaintiffs.
In a recent decision, the Court has granted the name brand defendants' (Wyeth, Schwarz & Alavan) motion to dismiss the New Jersey Plaintiffs' complaints against them. In these cases the Plaintiffs' ingested the generic form of Reglan and not a product that was produced or sold by the brand defendants. Based upon New Jersey law and precedent, this decision is applicable to all New Jersey plaintiffs' cases.
The recent Supreme Court decision PLIVA v. Mensing has been a significant hurdle for the Reglan litigation. The plaintiffs are currently working to overcome this hurdle, but it's definitely an uphill battle. The court is currently reviewing the Plaintiff and Defendant briefs on the Mensing issue. We hope to have a more substantive update once the issue is decided by the court, but right now we still exploring alternate avenues that may be available to our clients in the event of an unfavorable decision by the court.
Contact Us To Discover More About Reglan
If you face a medical issue regarding the use of Reglan, contact our firm at your earliest convenience. We offer free initial consultations, work on a contingency fee basis and are conveniently located in Midtown Manhattan. To contact a New York medication errors lawyer, call 888-335-9457.
- Memorandum of Decision on Brand Manufacturer's Motion to Dismiss
- September 1, 2011 Newsletter
- Plaintiff's Motion for Summary Judgment
- Generic Defendants- Motion to Dismiss
- Pliva v. Mensing Majority Opinion
- Pliva v. Mensing Dissenting Opinion
- Plaintiffs' Amended Brief in Opposition to Motion to Dismiss
- Reglan Newsletter- Winter 2012
You can also learn more by reviewing the latest news on our blog at: